Research suggests that Mucuna pruriens seed extracts may exert neuroprotective effects through multiple mechanisms, including antioxidant activity, reduction of neuroinflammation, and modulation of immune pathways, with evidence pointing to bioactive compounds such as L-DOPA, ursolic acid, and betulinic acid as likely contributors. Studies indicate these effects have been observed across several neurodegenerative disease models, including Parkinson's disease, Alzheimer's disease, ALS, stroke, and cerebral ischemia, with one in vitro study reporting neuroprotective activity superior to synthetic L-DOPA. The current body of evidence consists predominantly of reviews, preclinical animal studies, and in vitro cell models, with a 2025 systematic review noting that broader phytochemical research in this area faces significant challenges around bioavailability, standardization, and the absence of rigorous long-term clinical trials. While the overall direction of the available literature is supportive, the lack of large-scale human trials means that conclusions about therapeutic application in humans remain preliminary.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases. | Review | 2022 | Supports | 99 |
| Neuroprotective potential of Mucuna pruriens in cerebral ischemia: Evidence f... | Review | 2026 | Supports | 98 |
| Mucuna pruriens Seed Aqueous Extract Improved Neuroprotective and Acetylcholi... | Other | 2022 | Supports | 95 |
| Mucuna pruriens in Parkinson's and in some other diseases: recent advancement... | Review | 2020 | Supports | 95 |
| The Magic Velvet Bean of Mucuna pruriens. | Review | 2012 | Supports | 92 |
| Mucuna pruriens (L.) DC. seed extract inhibits lipopolysaccharide-induced inf... | Other | 2021 | Supports | 88 |
| Immunomodulation of Parkinson's disease using Mucuna pruriens (Mp). | Review | 2017 | Supports | 85 |
| Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechan... | Systematic review | 2025 | Supports | 75 |